3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
29
Carcinoma, Non-Small-Cell Lung
11
Liver Neoplasms
7
Lung Neoplasms
5
Urinary Bladder Neoplasms
4
Small Cell Lung Carcinoma
4
Neoplasms
4
Diabetes Mellitus, Insulin-Dependent, 12
4
Pancreatic Neoplasms
3
Colorectal Neoplasms
3
Cholangiocarcinoma
3
Biliary Tract Neoplasms
3
Adenocarcinoma Of Esophagus
3
Stomach Neoplasms
2
Neoplasm Metastasis
2
Mesothelioma, Malignant
2
Mesothelioma
2
Fallopian Tube Neoplasms
2
Carcinoma
2
Vascular Neoplasms
1
Urothelial Cancer
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Unresectable Hepatocellular Carcinoma
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Malignancies
1
Seminoma
1
Interventions
trastuzumab biosimilar HLX02
2
ribociclib
2
pertuzumab
2
Trastuzumab
2
Taxes
2
Specimen Handling
2
Paclitaxel
2
PF-05280014
2
Ontruzant
2
Ogivri
2
Magnetic Resonance Spectroscopy
2
Drug Therapy
2
Docetaxel
2
2C4 antibody
2
tucatinib
1
exemestane
1
durvalumab
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiation
1
Mastectomy, Segmental
1
Mastectomy
1
Letrozole
1
Immunoglobulin G
1
High-Energy Shock Waves
1
Genetic Testing
1
Fulvestrant
1
Fluorodeoxyglucose F18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage II Breast Cancer AJCC v8
×
tremelimumab
×
1 year
×
Clear all
No trials found.